The objectives of this paper are to compare in a multicenter setting patterns of regional cortical thickness in patients with relapsing–remitting multiple sclerosis (RRMS) and cognitive impairment (CI) and those cognitively preserved (CP), and explore the relationship between cortical thinning and cognitive performance.
Methods:
T1-weighted isotropic brain scans were collected at 3T from seven European centers in 60 RRMS patients and 65 healthy controls (HCs). Patients underwent clinical and neuropsychological examinations. Cortical thickness (CTh) measures were calculated using FreeSurfer (failing in four) and both lobar and vertex-based general linear model (GLM) analyses were compared between study groups.
Results:
Twenty (36%) MS patients were classified as CI. Mean global CTh was smaller in RRMS patients compared to HCs (left 2.43 vs. 2.53 mm, right 2.44 vs. 2.54 mm, p < 0.001). Multivariate GLM regional analysis showed significantly more temporal thinning in CI compared to CP patients. Verbal memory scores correlated to regional cortical thinning in the insula whereas visual memory scores correlated to parietal thinning.
Conclusions:
This multicenter study showed mild global cortical thinning in RRMS. The extent of thinning is less pronounced than previously reported. Only subtle regional differences between CI and CP patients were observed, some of which related to specific cognitive domains.
ChiaravallotiNDDeLucaJ. Cognitive impairment in multiple sclerosis. Lancet Neurol2008; 7: 1139–1151.
2.
RovarisMFilippiMFalautanoM. Relation between MR abnormalities and patterns of cognitive impairment in multiple sclerosis. Neurology1998; 50: 1601–1608.
3.
BenedictRHWeinstock-GuttmanBFishmanI. Prediction of neuropsychological impairment in multiple sclerosis: Comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol2004; 61: 226–230.
4.
SanfilipoMPBenedictRHWeinstock-GuttmanB. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis. Neurology2006; 66: 685–692.
5.
RoosendaalSDMoraalBPouwelsPJ. Accumulation of cortical lesions in MS: Relation with cognitive impairment. Mult Scler2009; 15: 708–714.
6.
HulstHESteenwijkMDVersteegA. Cognitive impairment in MS: Impact of white matter integrity, gray matter volume, and lesions. Neurology2013; 80: 1025–1032.
7.
FilippiMPreziosaPCopettiM. Gray matter damage predicts the accumulation of disability 13 years later in MS. Neurology2013; 81: 1759–1767.
8.
SailerMFischlBSalatD. Focal thinning of the cerebral cortex in multiple sclerosis. Brain2003; 126 (Pt 8): 1734–1744.
9.
CalabreseMRinaldiFMattisiI. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology2010; 74: 321–328.
10.
RamasamyDPBenedictRHCoxJL. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: A case-control study. J Neurol Sci2009; 282: 47–54.
11.
CaroneDABenedictRHDwyerMG. Semi-automatic brain region extraction (SABRE) reveals superior cortical and deep gray matter atrophy in MS. Neuroimage2006; 29: 505–514.
12.
RiccitelliGRoccaMAPaganiE. Mapping regional grey and white matter atrophy in relapsing–remitting multiple sclerosis. Mult Scler2012; 18: 1027–1037.
13.
CalabreseMAtzoriMBernardiV. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol2007; 254: 1212–1220.
14.
RaoSMLeoGJEllingtonL. Cognitive dysfunctionin multiple sclerosis. II. Impact on employment and social functioning. Neurology1991; 41: 692–696.
15.
KapoorRFurbyJHaytonT. Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: A randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Neurol2010; 9: 681–688.
16.
FilippiMRoccaMAPaganiE. Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage. J Neurol Neurosurg Psychiatry2014; 85: 851–858.
17.
RoccaMAValsasinaPHulstHE. Functional correlates of cognitive dysfunction in multiple sclerosis: A multicenter fMRI Study. Hum Brain Mapp2014; 35: 5799–5814.
18.
PolmanCHReingoldSCBanwellB. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol2011; 69: 292–302.
19.
BoringaJBLazeronRHReulingIE. The brief repeatable battery of neuropsychological tests: Normative values allow application in multiple sclerosis clinical practice. Mult Scler2001; 7: 263–267.
20.
HeatonRKCheluneGJTalleyJL. Wisconsin Card Sorting Test (WCST) manual, revised and expanded. Odessa, FL: Psychological Assessment Resources, 1993.
21.
PortaccioEGorettiBZipoliV. A short version of Rao’s Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. Clin Neuropsychol2009; 23: 268–275.
22.
DaleAMFischlBSerenoMI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage1999; 9: 179–194.
23.
FischlBSerenoMIDaleAM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage1999; 9: 195–207.
24.
HanXJovicichJSalatD. Reliability of MRI-derived measurements of human cerebral cortical thickness: The effects of field strength, scanner upgrade and manufacturer. Neuroimage2006; 32: 180–194.
25.
FischlBSalatDHBusaE. Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron2002; 33: 341–355.
26.
FischlBSalatDHvan der KouweAJ. Sequence-independent segmentation of magnetic resonance images. Neuroimage2004; 23 (Suppl 1): S69–S84.
27.
DesikanRSSégonneFFischlB. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage2006; 31: 968–980.
28.
NarayanaPAGovindarajanKAGoelP. Regional cortical thickness in relapsing remitting multiple sclerosis: A multi-center study. Neuroimage Clin2012; 2: 120–131.
29.
SteenwijkMDDaamsMPouwelsPJ. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Hum Brain Mapp2015; 36: 1796–1807.
30.
BattagliniMGiorgioAStromilloML. Voxel-wise assessment of progression of regional brain atrophy in relapsing–remitting multiple sclerosis. J Neurol Sci2009; 282: 55–60.
CharilADagherALerchJP. Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability. Neuroimage2007; 34: 509–517.
33.
BendfeldtKHofstetterLKusterP. Longitudinal gray matter changes in multiple sclerosis—differential scanner and overall disease-related effects. Hum Brain Mapp2012; 33: 1225–1245.
34.
RiccitelliGRoccaMAPaganiE. Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum Brain Mapp2011; 32: 1535–1543.
35.
NelsonFDattaSGarciaN. Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis. Mult Scler2011; 17: 1122–1129.
